Michael S. Steinberg

Hematology

320 Hospital Dr
Martinsville, VA 24112

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study.

Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study.

Journal: The Lancet. Oncology

Published: September 07, 2013

Showing 1-1 of 1

Last Updated: 09/26/2026